[
  {
    "ts": null,
    "headline": "Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?",
    "summary": "HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound.",
    "url": "https://finnhub.io/api/news?id=bfd61edd921f3ffa6e938b49b77d099df14ff0b5614183d6dedaaac35fd75dc7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757944800,
      "headline": "Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?",
      "id": 136766024,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound.",
      "url": "https://finnhub.io/api/news?id=bfd61edd921f3ffa6e938b49b77d099df14ff0b5614183d6dedaaac35fd75dc7"
    }
  },
  {
    "ts": null,
    "headline": "Unpacking Q2 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks",
    "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Danaher (NYSE:DHR) and the rest of the research tools & consumables stocks fared in Q2.",
    "url": "https://finnhub.io/api/news?id=46c1838e38fb6fe9d7b171dba34b4725921c1858eab88daadc084ce402e98c11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757910675,
      "headline": "Unpacking Q2 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks",
      "id": 136749664,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Danaher (NYSE:DHR) and the rest of the research tools & consumables stocks fared in Q2.",
      "url": "https://finnhub.io/api/news?id=46c1838e38fb6fe9d7b171dba34b4725921c1858eab88daadc084ce402e98c11"
    }
  }
]